Status:

RECRUITING

Focused Ultrasound Unilateral Pallidotomy for Medication-Refractory Limb Dystonia

Lead Sponsor:

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Collaborating Sponsors:

Azienda ULSS 3 Serenissima

IRCCS Centro Neurolesi Bonino Pulejo

Conditions:

Limb Dystonia

Idiopathic Dystonia

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to find out if a non-invasive procedure called focused ultrasound can safely and effectively treat limb dystonia in adults who have not improved with medications or ...

Detailed Description

The FUTURE study is a prospective, randomized, double-blind, sham-controlled, multicenter national clinical trial aimed at assessing the efficacy and safety of unilateral MR-guided focused ultrasound ...

Eligibility Criteria

Inclusion

  • Age 18-80 years
  • Able and willing to consent and attend visits
  • Idiopathic or hereditary limb dystonia (focal, segmental, or multifocal; isolated or combined)
  • Refractory to oral therapy and botulinum toxin
  • Stable medication for ≥30 days and ≥90 days since last BoNT
  • Capable of communicating during Exablate procedure

Exclusion

  • Acquired secondary dystonia
  • Dementia or other neurodegenerative disorders
  • Any clinically significant or unstable medical condition, which, in the opinion of the principal investigator or the clinician delegated by the principal investigator, may put the participant at risk when participating in the study (e.g., unstable heart disease or coagulopathy; uncontrolled psychiatric comorbidity)
  • Prior deep brain stimulation or other brain surgery
  • Any contraindication to MRI
  • Skull Density Ratio (SDR) \< 0.40
  • Significant brain lesions (eg brain tumor, significant white matter lesions or globus pallidus interna lesions on baseline MRI)
  • Pregnancy

Key Trial Info

Start Date :

January 27 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 28 2027

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT07168850

Start Date

January 27 2025

End Date

February 28 2027

Last Update

September 11 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Azienda ULSS3 Serenissima

Mestre, (Venice), Italy, 30174

2

IRCCS Centro Neurolesi "Bonino-Pulejo"

Messina, Italy, 98124

3

Fondazione IRCCS Istituto Neurologico Carlo Besta

Milan, Italy, 20133

4

Azienda Ospedaliera Ospedali Riuniti Villa Sofia

Palermo, Italy, 90146